Multiple Sclerosis International Federation

 
 
News
Donate advanced search
print version print this page
 

inside
News:

 

  Betaseron “BENEFIT” follow-up study results published
In a study just published, researchers have shown for the first time that early treatment can slow the rate at which disability progresses in individuals who have had a first event suggestive of multiple sclerosis but who have not yet been diagnosed with definite MS.

To read more, please click on the link below.


Source: US National MS Society
Weblink: click here

Copyright &<br>Link Policy Copyright &
Link Policy
Privacy Policy Privacy Policy back to top
Disclaimer Disclaimer Acknowledgements Acknowledgements
back to top  back to top  
Email Update Email Update Edit User Details Edit User Details Feedback Feedback Glossary Glossary Site Map Site Map
Back to top Back to top